I Cell Disease News and Research

RSS
Hydroxyurea treatment improves pulmonary function decline in children with sickle cell disease

Hydroxyurea treatment improves pulmonary function decline in children with sickle cell disease

Musashi-2 protein regulates function, development of blood stem cells

Musashi-2 protein regulates function, development of blood stem cells

Key opinions leaders to discuss role of cyclophosphamide in the field of HSCT

Key opinions leaders to discuss role of cyclophosphamide in the field of HSCT

Patient enrollment completed in vepoloxamer Phase 3 study for treatment of sickle cell disease

Patient enrollment completed in vepoloxamer Phase 3 study for treatment of sickle cell disease

Duchenne muscular dystrophy: direct effect on muscle stem cells? An interview with Dr Rudnicki

Duchenne muscular dystrophy: direct effect on muscle stem cells? An interview with Dr Rudnicki

Three Case Western faculty members receive funding to develop new diagnostic technologies

Three Case Western faculty members receive funding to develop new diagnostic technologies

NHS Blood and Transplant now offers more detailed blood testing for patients with haemoglobinopathies

NHS Blood and Transplant now offers more detailed blood testing for patients with haemoglobinopathies

UC Berkeley researchers make major improvement in CRISPR-Cas9 gene editing technology

UC Berkeley researchers make major improvement in CRISPR-Cas9 gene editing technology

PD-L1 inhibition well-tolerated, active in metastatic RCC

PD-L1 inhibition well-tolerated, active in metastatic RCC

Hydroxyurea could be a viable option for children with sickle cell disease

Hydroxyurea could be a viable option for children with sickle cell disease

St. Jude scientists develop interactive tool to advance understanding of mutations that fuel pediatric cancer

St. Jude scientists develop interactive tool to advance understanding of mutations that fuel pediatric cancer

SCCA's Fred Hutch Bone Marrow Transplant Program recognized for outstanding survival rates

SCCA's Fred Hutch Bone Marrow Transplant Program recognized for outstanding survival rates

Treatment with antiplatelet therapy does not reduce pain crises in children with sickle cell disease

Treatment with antiplatelet therapy does not reduce pain crises in children with sickle cell disease

New technology may facilitate early detection of sickle cell disease for infants in developing countries

New technology may facilitate early detection of sickle cell disease for infants in developing countries

Research shows significant step toward improving outcomes, reducing treatment burden for SCD patients

Research shows significant step toward improving outcomes, reducing treatment burden for SCD patients

Sickle cell disease treatment may help protect kidney function in patients

Sickle cell disease treatment may help protect kidney function in patients

Boston Children's Hospital selects Vijay G. Sankaran to receive Rising Star Award

Boston Children's Hospital selects Vijay G. Sankaran to receive Rising Star Award

UConn-led researchers develop simple technique for diagnosis and monitoring of sickle cell disease

UConn-led researchers develop simple technique for diagnosis and monitoring of sickle cell disease

Halozyme Therapeutics announces initiation of rivipansel Phase 1 clinical trial

Halozyme Therapeutics announces initiation of rivipansel Phase 1 clinical trial

Mast Therapeutics begins vepoloxamer Phase 2 study in patients with chronic heart failure

Mast Therapeutics begins vepoloxamer Phase 2 study in patients with chronic heart failure